SERS-based detection of haptoglobin in ovarian cyst fluid as a point-of-care diagnostic assay for epithelial ovarian cancer
Perumal, J. ; Mahyuddin, A.P. ; Balasundaram, G. ; Goh, D. ; Fu, C.Y. ; Kazakeviciute, A. ; Dinish, U.S. ; ; Olivo, M.
Perumal, J.
Balasundaram, G.
Goh, D.
Fu, C.Y.
Kazakeviciute, A.
Dinish, U.S.
Olivo, M.
Citations
Altmetric:
Alternative Title
Abstract
Purpose: To evaluate haptoglobin (Hp) in ovarian cyst fluid as a diagnostic biomarker for epithelial ovarian cancers (EOCs) using surface-enhanced Raman spectroscopy (SERS)-based in vitro diagnostic assay for use in an intraoperative setting. Methods: SERS-based method was used to detect and quantify Hp in archived ovarian cyst fluids collected from suspicious ovarian cysts and differentiate benign tumors from EOCs. The diagnostic performance of SERS-based assay was verified against the histopathology conclusions and compared with the results of CA125 test and frozen sections. Results: Hp concentration present in the clinical cyst fluid measured by SERS was normalized to 3.3 mg/mL of standard Hp. Normalized mean values for patients with benign cysts were 0.65 (n=57) and malignant cysts were 1.85 (n=54), demonstrating a significantly (P<0.01) higher Hp in malignant samples. Verified against histology, Hp measurements using SERS had a sensitivity of 94% and specificity of 91%. Receiver operating characteristic curve analysis of SERS-based Hp measurements resulted in area under the curve of 0.966±0.03, establishing the robustness of the method. CA125 test on the same set of patients had a sensitivity of 85% and specificity of 90%, while frozen section analysis on 65 samples had 100% sensitivity and specificity. Conclusion: With a total execution time of <10 minutes and consistent performance across different stages of cancer, the SERS-based Hp detection assay can serve as a promising intraoperative EOC diagnostic test. © 2019 Perumal et al.
Keywords
Epithelial ovarian cancer, Haptoglobin, Ovarian cyst fluid, Point-of-care diagnostics, Surface-enhanced Raman spectroscopy
Source Title
Cancer Management and Research
Publisher
Dove Medical Press Ltd
Series/Report No.
Collections
Rights
Attribution-NonCommercial 4.0 International
Date
2019
DOI
10.2147/CMAR.S185375
Type
Article